1-12 of 12
Xiaoqin Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial

Xiaoqin Chen, Yun Wang, Weida Wang, Hua Wang, Bingyi Wu, Yang Liang, Zhongjun Xia
Journal: Blood
Blood (2024) 144 (Supplement 1): 7025.
https://doi.org/10.1182/blood-2024-204564
Published: 2024
Journal Articles

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients with Newly Diagnosed Multiple Myeloma (NDMM): Insights from a Multi-Center Study

Dong Liang, Demei Feng, Qiaoli Wang, Shenrui Bai, Min Zeng, Bo Lu, Xiaoqing Li, Zhiqiang Sun, Jianyun Li, Huanhuan Zhou, Jialu Zhang, Xiaoqin Chen, Zhongjun Xia, Yang Liang, Hua Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7064.
https://doi.org/10.1182/blood-2024-204519
Published: 2024
Journal Articles

Lactate Metabolism-Related Genes to Predict the Clinical Outcome and Molecular Characteristics of Multiple Myeloma

Lingling Shu, Ziang Zhu, Yang Li, Hanying Huang, Xiaoqin Chen, Zhongjun Xia, Yang Liang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4693.
https://doi.org/10.1182/blood-2024-207432
Published: 2024
Journal Articles

Initial Results from a Phase 1 Study of TQB2934, a BCMA × CD3 Bispecific Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple

Peng Liu, Junling Zhuang, Zhongjun Xia, Bingzong Li, Songfu Jiang, Yian Zhang, Wei Wang, Xiaoqin Chen, Xiaohui Zhang, Shujuan Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 1998.
https://doi.org/10.1182/blood-2024-209665
Published: 2024
Journal Articles

Real-World Outcome of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma: A Multicenter Propensity Score Matched Case Series Study

Weida Wang, Yaofang Hu, Yun Wang, Xiaoqin Chen, Zhongjun Xia
Journal: Blood
Blood (2022) 140 (Supplement 1): 12589–12590.
https://doi.org/10.1182/blood-2022-171132
Published: 2022
Journal Articles

Identification of a Novel Drug Sensitivity Biomarker Neuregulin-2 for Venetoclax in Non-t(11;14) Multiple Myeloma

Yujun Dai, Xue-Ping Li, Fang Hu, Jinyuan Li, Yang Liang, Da-Wei Wang, Zhongjun Xia, Xiaoqin Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 459.
https://doi.org/10.1182/blood-2021-150370
Published: 2021
Journal Articles

The Expression of Paks and Its Clinical Significance in T-Cell Lymphoblastic Lymphoma

Qingqing Cai, PhD, Ning Su, MM, Yu Fang, BMBS, Xu Chen, MDPhD, Xiaopeng Tian, MDPhD, Shuyun Ma, MM, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Tongyu Lin, MD PhD, Huiqiang Huang, MDPhD, Zhiming Li, MD PhD, Xueyi Pan, MDPhD, Yi Xia, MD PhD, Panpan Liu, MD PhD, Xuanye Zhang, MDPhD, Hang Yang, MD PhD, Stephen Yang Liang, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–16.
https://doi.org/10.1182/blood-2020-136975
Published: 2020
Journal Articles

Development and Validation of a Risk Assessment Model for Early Infection during the First 3 Months in Patients with Newly Diagnosed Multiple Myeloma

Yufeng Shang, Weida Wang, MD PhD, Minghui Liu, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Fuling Zhou, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-141735
Published: 2020
Journal Articles

A Phase 1 Dose-Escalation Study of LH031, a Kinesin Spindle Protein Inhibitor, in Patients with Refractory/Resistance Multiple Myeloma

Zhongjun Xia, MDPhD, Su Li, Xiaoqin Chen, MDPhD, Weida Wang, MD PhD, Yan Song
Journal: Blood
Blood (2020) 136 (Supplement 1): 37.
https://doi.org/10.1182/blood-2020-137346
Published: 2020
Journal Articles

The Role of Interim F-18 FDG PET/CT in Patients of T Lymphoblastic Leukemia/Lymphoma Treated with ALL-Type Regimens

Liang Wang, MD, Zhongjun Xia, MD, Xiaoqin Chen, MD, Wen Long, MD
Journal: Blood
Blood (2015) 126 (23): 5015.
https://doi.org/10.1182/blood.V126.23.5015.5015
Published: 2015
Journal Articles

Phase 2 Trial of Concurrent Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-Induced Peripheral Neuropathy in Patients of Multiple Myeloma

Liang Wang, MD, Zhongjun Xia, MD, Xiaoqin Chen, MD
Journal: Blood
Blood (2015) 126 (23): 5399.
https://doi.org/10.1182/blood.V126.23.5399.5399
Published: 2015
Journal Articles

Small Compound 6- O -Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potential In Multiple Myeloma

Ying Liu, Xiaoqin Chen, Yongxian Cheng, Guangbiao Zhou, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 5043.
https://doi.org/10.1182/blood.V116.21.5043.5043
Published: 2010